Golden Road Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Golden Road Advisors's LLY Position: Q2 2026 in Review
Golden Road Advisors increased its Eli Lilly (LLY) stake by 0.82% in Q2 2026, buying an estimated $4.09K and bringing the position to 492 shares worth $590K. The position accounts for 0.29% of the portfolio, ranked #36.
Golden Road Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,595 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Golden Road Advisors held 492 shares of Eli Lilly worth $590K as of Q2 2026.
- Golden Road Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 0.29% of Golden Road Advisors's portfolio in Q2 2026, its #36 holding.
- Golden Road Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,595 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Golden Road Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.